Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N 2-benzylguanosine limits the binding sites occupied by PKR

Sujiet Puthenveetil, Eduardo A. Véliz, Peter A. Beal

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Examining viral decoys: Epstein-Barr virus (EBV) generates small RNA inhibitors of the human RNA-dependent protein kinase (PKR). We demonstrate that chemical synthesis of analogues of the EBV PKR inhibitor EBER1 bearing single N2-benzylguanosine substitutions (BnG6 or BnG29) can be used to control the way PKR binds this RNA.

Original languageEnglish (US)
Pages (from-to)383-386
Number of pages4
JournalChemBioChem
Volume5
Issue number3
DOIs
StatePublished - Mar 5 2004
Externally publishedYes

Fingerprint

eIF-2 Kinase
Human Herpesvirus 4
Viruses
Bearings (structural)
Binding Sites
RNA
Substitution reactions
Epstein-Barr virus encoded RNA 1
N2-benzylguanosine

Keywords

  • Epstein-Barr virus
  • Nucleic acids
  • Proteins
  • RNA recognition
  • RNA-dependent protein kinase

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N 2-benzylguanosine limits the binding sites occupied by PKR. / Puthenveetil, Sujiet; Véliz, Eduardo A.; Beal, Peter A.

In: ChemBioChem, Vol. 5, No. 3, 05.03.2004, p. 383-386.

Research output: Contribution to journalArticle

Puthenveetil, Sujiet ; Véliz, Eduardo A. ; Beal, Peter A. / Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N 2-benzylguanosine limits the binding sites occupied by PKR. In: ChemBioChem. 2004 ; Vol. 5, No. 3. pp. 383-386.
@article{75688b7c69f74fffacd63e18a8beb769,
title = "Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N 2-benzylguanosine limits the binding sites occupied by PKR",
abstract = "Examining viral decoys: Epstein-Barr virus (EBV) generates small RNA inhibitors of the human RNA-dependent protein kinase (PKR). We demonstrate that chemical synthesis of analogues of the EBV PKR inhibitor EBER1 bearing single N2-benzylguanosine substitutions (BnG6 or BnG29) can be used to control the way PKR binds this RNA.",
keywords = "Epstein-Barr virus, Nucleic acids, Proteins, RNA recognition, RNA-dependent protein kinase",
author = "Sujiet Puthenveetil and V{\'e}liz, {Eduardo A.} and Beal, {Peter A.}",
year = "2004",
month = "3",
day = "5",
doi = "10.1002/cbic.200300816",
language = "English (US)",
volume = "5",
pages = "383--386",
journal = "ChemBioChem",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag",
number = "3",

}

TY - JOUR

T1 - Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N 2-benzylguanosine limits the binding sites occupied by PKR

AU - Puthenveetil, Sujiet

AU - Véliz, Eduardo A.

AU - Beal, Peter A.

PY - 2004/3/5

Y1 - 2004/3/5

N2 - Examining viral decoys: Epstein-Barr virus (EBV) generates small RNA inhibitors of the human RNA-dependent protein kinase (PKR). We demonstrate that chemical synthesis of analogues of the EBV PKR inhibitor EBER1 bearing single N2-benzylguanosine substitutions (BnG6 or BnG29) can be used to control the way PKR binds this RNA.

AB - Examining viral decoys: Epstein-Barr virus (EBV) generates small RNA inhibitors of the human RNA-dependent protein kinase (PKR). We demonstrate that chemical synthesis of analogues of the EBV PKR inhibitor EBER1 bearing single N2-benzylguanosine substitutions (BnG6 or BnG29) can be used to control the way PKR binds this RNA.

KW - Epstein-Barr virus

KW - Nucleic acids

KW - Proteins

KW - RNA recognition

KW - RNA-dependent protein kinase

UR - http://www.scopus.com/inward/record.url?scp=4544352681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544352681&partnerID=8YFLogxK

U2 - 10.1002/cbic.200300816

DO - 10.1002/cbic.200300816

M3 - Article

C2 - 14997533

AN - SCOPUS:4544352681

VL - 5

SP - 383

EP - 386

JO - ChemBioChem

JF - ChemBioChem

SN - 1439-4227

IS - 3

ER -